New hope for kids with tough liver cancer: Triple-Threat therapy trial opens

This study is testing a new combination of three drugs—an immunotherapy, a targeted therapy, and a chemotherapy—for children and teenagers with advanced hepatoblastoma, a type of liver cancer, that has come back or hasn't responded to standard treatments. The goal is to see if this combination can better control the cancer and help patients live longer. Researchers will enroll about 24 young patients to receive the treatment and closely monitor how they respond.